leadf
logo-loader
viewCreso Pharma Ltd
(
ASX:CPHOTCQB:COPHF
)

Creso Pharma subsidiary Mernova granted sales license from Health Canada

Creso Pharma (ASX:CPH) subsidiary Mernova managing director Jack Yu and vice president Isaac Allen joined Steve Darling from Proactive to discuss the granting of their sales license from Health Canada and what it allows them to do.

Isaac Allen tells Proactive they are gearing up sales efforts and see a number of avenues to increase sales growth.

Quick facts: Creso Pharma Ltd

Follow
ASX:CPH

Price: 0.11 AUD

Market Cap: $132.17 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Sipa Resources focused on northern Pilbara resources hotspot

Sipa Resources Ltd (ASX:SRI) managing director Pip Darvall outlined the company’s busy work program in the northern Pilbara of Western Australia, encompassing the Paterson Province, during this week’s Proactive Resources Webinar. A primary focus is the Warralong Gold Project that is...

22 hours, 2 minutes ago

2 min read